Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Chemotherapy is vital for cancer treatment but often fails due to multidrug resistance (MDR).
• P-glycoprotein (P-gp) overexpression is a primary mechanism driving MDR by exporting chemotherapy drugs out of cancer cells.
• Existing P-gp inhibitors have limitations, including lack of specificity and dose-limiting toxicities.

Purpose of the Study:

• To review the role of accessory proteins in regulating P-glycoprotein (P-gp) expression and function.
• To explore how these proteins contribute to the development of multidrug resistance (MDR) in cancer cells.
• To identify novel therapeutic targets for overcoming P-gp-mediated MDR.

Main Methods:

• Literature review of recent studies on P-gp accessory proteins and MDR.
• Analysis of pathways and proteins that regulate P-gp expression.
• Discussion of the potential of these proteins as therapeutic targets.

Main Results:

• Accessory proteins play a crucial role in establishing the functional P-gp phenotype in cancer cells.
• Some accessory proteins may form an interactive complex that contributes to MDR.
• Other pathways and proteins also influence P-gp expression and function.

Conclusions:

• Accessory proteins are key regulators of P-gp and are essential for MDR.
• Targeting these accessory proteins presents a promising strategy to circumvent P-gp-mediated MDR.
• This approach offers new clinical opportunities to improve the efficacy of anticancer chemotherapy.